glp 2 retatrutide Unapproved weight loss drug causes extreme side effects CAS 2381089-83-2 (Retatrutide) - BOC

Whilst not currently licensed for PCOS in the UK, growing evidence suggests GLP-1 therapy may address both metabolic and reproductive features of this complex condition

Introduction Parkinsons disease (PD) is one of the most disabling diseases globally (1)

Safety, Side Effects, and Personalized Monitoring As with any medication, semaglutide may have side effects, including gastrointestinal symptoms such as nausea or diarrhea, especially at the start of treatment

This was a monotherapy trial no background diabetes medications in adults with recent-onset disease and A1C between 7.0% and 9.5%, randomized over 40 weeks